New research results further suggest that belimumab (Benlysta®) may be effective in people with lupus who have limited, or no organ damage accrued prior to starting treatment. This information supports previous real-world observations and provides important clinical guidance on the daily use of belimumab therapy in people with lupus.

Read the study